119 related articles for article (PubMed ID: 15763450)
21. One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life.
Tsolaki V; Pastaka C; Karetsi E; Zygoulis P; Koutsokera A; Gourgoulianis KI; Kostikas K
Respir Med; 2008 Jun; 102(6):904-11. PubMed ID: 18280131
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between SGRQ score and pulmonary function and its influencing factors in patients with chronic obstructive pulmonary disease].
Liu R; DU YP; He B
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1533-7. PubMed ID: 21914365
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
25. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
[TBL] [Abstract][Full Text] [Related]
26. A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.
Cartmell MT; O'Reilly DA; Porter C; Kingsnorth AN
J Hepatobiliary Pancreat Surg; 2004; 11(4):255-9. PubMed ID: 15368110
[TBL] [Abstract][Full Text] [Related]
27. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
28. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
[TBL] [Abstract][Full Text] [Related]
30. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
Sanada S; Tanaka T; Kameyoshi Y; Hide M
Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
[TBL] [Abstract][Full Text] [Related]
32. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
John M; Bosse S; Oltmanns U; Schumacher A; Witt C
Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
[TBL] [Abstract][Full Text] [Related]
33. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].
Sun TY; Guo YF; Xu XM; Zhang HS; Hou J; Ke HX; Li YM; Fang BM; Ming SH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387
[TBL] [Abstract][Full Text] [Related]
34. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Lu S; Liu N; Dass SB; Reiss TF
J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
36. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
Ozdemir T; Geçkin E; Oğüş C; Cilli A
Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
[TBL] [Abstract][Full Text] [Related]
37. Montelukast therapy and psychological distress in chronic obstructive pulmonary disease (COPD): a preliminary report.
Gueli N; Verrusio W; Linguanti A; De Santis W; Canitano N; Ippoliti F; Marigliano V; Cacciafesta M
Arch Gerontol Geriatr; 2011; 52(1):e36-9. PubMed ID: 20478636
[TBL] [Abstract][Full Text] [Related]
38. Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease.
Pellegrini M; Fanin D; Nowicki Y; Guarnieri G; Bordin A; Faggian D; Plebani M; Saetta M; Maestrelli P
Respir Med; 2005 Jun; 99(6):748-54. PubMed ID: 15878492
[TBL] [Abstract][Full Text] [Related]
39. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
Bouchelouche K; Nordling J; Hald T; Bouchelouche P
J Urol; 2001 Nov; 166(5):1734-7. PubMed ID: 11586212
[TBL] [Abstract][Full Text] [Related]
40. Temazepam 10mg does not affect breathing and gas exchange in patients with severe normocapnic COPD.
Stege G; Heijdra YF; van den Elshout FJ; van de Ven MJ; de Bruijn PJ; van Sorge AA; Dekhuijzen PN; Vos PJ
Respir Med; 2010 Apr; 104(4):518-24. PubMed ID: 19910177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
